ABCL
AbCellera Biologics Inc.
$3.61
+$0.04(+1.26%)
20
Overall
--
Value
18
Tech
23
Quality
Market Cap
$1.02B
Volume
1.89M
52W Range
$1.89 - $6.52
Target Price
$9.00
EPS Estimates Overview
| Current Quarter | $-0.18 | Next Quarter | $-0.16 |
| Current Year | $-0.65 | Next Year | $-0.67 |
| QoQ Growth | +11.1% | YoY Growth | -3.1% |
| 3Y EPS CAGR | N/A | Target Price | $9.00 |
| Consensus | Buy | Upside | +149.7% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABCL | $3.61 | +1.3% | 1.89M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get AbCellera Biologics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW